Godavari Drugs Limited (BOM:530317)

Godavari Drugs Income Statement

Financials in millions INR. Fiscal year is April - March.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 31, 2025	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021
Operating Revenue	981.48	1,134	1,567	1,596	1,611	1,227
Other Revenue	5.47	7.55	5.1	-	1.55	1.43
Revenue	986.94	1,141	1,572	1,596	1,613	1,228
Revenue Growth (YoY)	-22.20%	-27.42%	-1.50%	-1.01%	31.31%	28.26%
Cost of Revenue	709.32	828.66	1,222	1,295	1,328	978.97
Gross Profit	277.63	312.39	350.35	301.26	284.42	249.17
Selling, General & Admin	59.54	52.05	52.56	49.59	50.65	40.43
Other Operating Expenses	104.68	131.45	158.07	133.08	116.86	108.91
Operating Expenses	189.13	207.97	230.57	202.11	184.48	161.56
Operating Income	88.5	104.42	119.78	99.15	99.94	87.6
Interest Expense	-41.31	-47.32	-49.15	-39.27	-28.49	-31.89
Interest & Investment Income	1.06	1.06	1.07	1.29	1.1	0.8
Currency Exchange Gain (Loss)	-3.07	-3.07	-1.58	-18.03	-2.34	1.87
Other Non Operating Income (Expenses)	0.82	0.82	-	3.93	-	-1.32
EBT Excluding Unusual Items	45.99	55.91	70.12	47.05	70.21	57.06
Gain (Loss) on Sale of Assets	0.35	0.35	-	-	-	-
Other Unusual Items	2.51	-	-0.9	2.3	-	-
Pretax Income	48.85	56.25	69.22	49.35	70.21	57.06
Income Tax Expense	11.94	12.45	13.73	11.49	17.75	15.78
Net Income	36.92	43.8	55.49	37.86	52.45	41.28
Net Income to Common	36.92	43.8	55.49	37.86	52.45	41.28
Net Income Growth	-39.96%	-21.07%	46.57%	-27.82%	27.06%	106.33%
Shares Outstanding (Basic)	8	8	8	8	8	8
Shares Outstanding (Diluted)	8	8	8	8	8	8
Shares Change (YoY)	-0.06%	-0.04%	0.03%	0.01%	-0.10%	0.15%
EPS (Basic)	4.91	5.82	7.37	5.03	6.97	5.48
EPS (Diluted)	4.91	5.82	7.37	5.03	6.97	5.48
EPS Growth	-39.93%	-21.03%	46.52%	-27.83%	27.19%	106.01%
Free Cash Flow	-	-88.02	52.12	38.81	59.85	-3.44
Free Cash Flow Per Share	-	-11.70	6.92	5.16	7.95	-0.46
Gross Margin	28.13%	27.38%	22.28%	18.87%	17.64%	20.29%
Operating Margin	8.97%	9.15%	7.62%	6.21%	6.20%	7.13%
Profit Margin	3.74%	3.84%	3.53%	2.37%	3.25%	3.36%
Free Cash Flow Margin	-	-7.71%	3.31%	2.43%	3.71%	-0.28%
EBITDA	112.98	128.9	144.26	118.58	116.9	99.83
EBITDA Margin	11.45%	11.30%	9.18%	7.43%	7.25%	8.13%
D&A For EBITDA	24.48	24.48	24.48	19.44	16.96	12.23
EBIT	88.5	104.42	119.78	99.15	99.94	87.6
EBIT Margin	8.97%	9.15%	7.62%	6.21%	6.20%	7.13%
Effective Tax Rate	24.44%	22.14%	19.83%	23.28%	25.29%	27.66%
Revenue as Reported	989.17	1,143	1,573	1,603	1,614	1,231

Source: S&P Global Market Intelligence. Standard template. Financial Sources.